The UK’s efforts to tackle the monkeypox outbreak will receive a £2 million boost with the creation of a new research consortium. The consortium The consortium will work together to develop better diagnostic tests, identify potential therapies and study vaccine effectiveness and the virus’ spread. The consortium brings together 25 leading researchers and scientists from 12 institutions across the UK. It has received £2 million from the Biotechnology and Biosciences Research Council (BBSRC) and the Medical Research Council (MRC), both part of UK Research and Innovation (UKRI). The consortium is led by The Pirbright Institute and the MRC-University of Glasgow Centre for Virus Research. The researchers at institutes and universities will work closely with experts at government agencies to study the current outbreak and inform the public health response in the UK and internationally. These agencies include: Animal and Plant Health Agency UK Health Security Agency (UKHSA) Defence Science and Technology Laboratory (Dstl) https://www.ukri.org/news/new-uk-research-consortium-to-tackle-monkeypox-outbreak/
"Up to 16 September 2022, there were 3,439 confirmed and 146 highly probable monkeypox cases in the UK: 3,585 in total. Of these, 93 were in Scotland, 34 were in Northern Ireland, 46 were in Wales and 3,412 were in England." https://www.gov.uk/government/publi...ak-epidemiological-overview-20-september-2022
